-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Tempest Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2018 to Q2 2024.
- Tempest Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $155K, a 86.7% increase year-over-year.
- Tempest Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $416K, a 33.5% decline year-over-year.
- Tempest Therapeutics, Inc. annual Depreciation for 2023 was $381K, a 40.3% decline from 2022.
- Tempest Therapeutics, Inc. annual Depreciation for 2022 was $638K, a 70.6% increase from 2021.
- Tempest Therapeutics, Inc. annual Depreciation for 2021 was $374K, a 10.3% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)